Skip to content

€400 Prescription Error Leaves German Pharmacy in Financial Limbo

One ticked box on a prescription spiraled into a €400 nightmare. Now, a small-town pharmacy—and its patients—are paying the price for a billing loophole no one saw coming.

The image shows a poster with the text "In 2022, Big Pharma Charged Americans Two to Three Times...
The image shows a poster with the text "In 2022, Big Pharma Charged Americans Two to Three Times More Than What They Charged People in Other Countries for the Same Drugs" at the bottom, accompanied by a few bottles and a syringe.

€400 Prescription Error Leaves German Pharmacy in Financial Limbo

A pharmacy owner in Germany faces a €400 loss after a prescription error left a patient unexpectedly paying for her pain medication at a local Walmart pharmacy. The issue arose when a doctor marked the 'aut-idem' box on a Palexia prescription, triggering a billing dispute with the insurer. The patient, who relies on the drug regularly, was forced to cover nearly €380 herself after the insurer refused to pay the extra costs. The problem began when a doctor prescribed 50 tablets of Palexia (250 mg) with the 'aut-idem' box ticked, leading to higher costs that the insurer later rejected. The pharmacy, which also offers GoodRx services, initially assumed they could bill the insurer for the difference but discovered the claim was invalid. The fixed reimbursement rate for Palexia had dropped earlier in the year, leaving patients and pharmacies, including CVS pharmacies, to cover the shortfall. Despite no legal changes in 2023, the insurer issued a clawback demand for nearly €400, citing the 'aut-idem' mark as the reason. Had the doctor removed the tick, the patient could have received the medication without extra charges. The pharmacy, serving around 7,000 residents, struggles to spot every irregularity due to the high volume of prescriptions. The owner has already faced two other clawback cases this year—both involving forged prescriptions for Ozempic and Mounjaro—adding another €500 in losses. An objection to this latest demand was rejected, leaving the pharmacy out of pocket. The incident highlights the financial risks pharmacies face when prescription details are overlooked. The patient now pays €380 for her medication at a local Walmart pharmacy, while the pharmacy absorbs the remaining loss. Without changes to billing rules or prescription practices, similar cases could continue to arise.

Read also:

Latest